Paraza Pharma is pleased to announce a recent joint publication in collaboration with Genentech entitled: Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model, ACS Med. Chem. Lett., 2024, ASAP
